• Contact us
  • E-Submission
ABOUT
BROWSE ARTICLES
JOURNAL POLICIES
FOR CONTRIBUTORS

Articles

Page Path

Original Article

Viral Serologic Markers in Patients with Acute and Chronic Liver Diseases

Il Hwan Moon, M.D., Gap Ho Lee, M.D., Lee Gap Park, M.D.
The Ewha Medical Journal 1984;7(4):227-233. Published online: July 24, 2015

Department of Internal Medicine, College of Medicine, Ewha Womans University, Korea.

Corresponding author: Lee Gap Park. Department of Internal Medicine, College of Medicine, Ewha Womans University, Korea.

Copyright © 1984. Ewha Womans University School of Medicine

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 21 Views
  • 0 Download
prev next
  • Vial serologic markers for hepatitis B virus infection are known as HBsAg, anti-HBs, anti-HBc and anti-HBe, and also recently IgM class antibodies are measurable for both hepatitis A and B. Five serologic markers for hepatitis B virus infection were measured routinely in patients with acute and chronic liver diseases and IgM class antibodies were evaluated in patients with acute viral hepatitis. The results were as follows: 1) Men are more frequently affected than women in chronic liver diseases and as the disease progressed to chronic diseases, the mean ages of patients increased. 2) Positivities of HBsAg were 79.7% in acute viral hepatitis, 88.9% in chronic hepatitis, 47.2% in cirrhosis and 72.0% in primary liver cancer respectively. 3) In forty cases of acute viral hepatitis, IgM anti-HBe was positive in two HBsAg negative cases and negative in three HBsAg positive cases. 4) Anti-HBc was positive in majority of various liver diseases and appeared usually with HBsAg or anti-HBs,but sigly positive in minority of patients. 5) Positivities of HBeAg in HBsAg positive liver diseases were 68.1% in acute viral hepatitis, 75.0% in chronic hepatitis, 41.2% in cirrhosis and 61.1% in primary liver cancer respectively.

Figure & Data

References

    Citations

    Citations to this article as recorded by  

      Download Citation

      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

      Format:

      Include:

      Viral Serologic Markers in Patients with Acute and Chronic Liver Diseases
      Ihwa Ŭidae chi. 1984;7(4):227-233.   Published online July 24, 2015
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

      Format:
      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      Include:
      • Citation for the content below
      Viral Serologic Markers in Patients with Acute and Chronic Liver Diseases
      Ihwa Ŭidae chi. 1984;7(4):227-233.   Published online July 24, 2015
      Close
      Viral Serologic Markers in Patients with Acute and Chronic Liver Diseases
      Viral Serologic Markers in Patients with Acute and Chronic Liver Diseases
      TOP